We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DiaSys Acquires Intersep

By HospiMedica staff writers
Posted on 17 Oct 2000
DiaSys Corp. More...
(New York, NY, USA) has acquired Intersep Limited, a UK-based manufacturer of consumable laboratory products, reagents, and test kits. DiaSys designs, manufactures, and distributes medical laboratory equipment. Intersep will become a wholly owned subsidiary of DiaSys, which will consolidate all European manufacturing, sales, and service operations under the new subsidiary's managing director, Paul Reardon.

Todd M. DeMatteo, president and CEO of DiaSys, stated that the company acquired Intersep because of the tremendous product and market synergies between the two firms. He said that Intersep's consumable products and reagents are like "blades” for the "razors” of DiaSys. DeMatteo also noted that Intersep has a strong European presence, a network of distributors, and several key European certifications, all of which are indispensable to DiaSys' strategic growth plan.

"DiaSys is a good acquisition partner because it is well-organized and has a very sound strategic growth plan,” said Intersep's Reardon. He stated that the combination of the companies not only furthers the objectives of DiaSys' growth plan but also creates a distribution platform for numerous additional products and system-selling strategies.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Aspiration System
VACUSAFE
New
Clinical Informatics Platform
CLARION™
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.